SHERIDAN, WYOMING -- July 10, 2026 -- Kahn Swick & Foti, LLC (KSF) continues its investigation into Inspire Medical Systems, Inc. (NYSE: INSP) and its officers and directors for potential breaches of fiduciary duties following significant product launch failures and an 80% reduction in earnings guidance. The law firm, led by former Louisiana Attorney General Charles C. Foti, Jr., is examining whether company leadership violated federal securities laws or state fiduciary obligations when disclosing information about the Inspire V device launch.
Inspire V Device Launch Failures Trigger 80% Earnings Guidance Cut
Inspire Medical disclosed in August 2025 that its Inspire V device launch faced an elongated timeframe. This admission contradicted repeated company assurances that all regulatory, technical, and commercial prerequisites had been met. The company revealed that many medical centers failed to complete required training, contracting, and onboarding before purchasing and implanting the device. Software updates for claims submissions did not take effect until early July. Excess inventory further weakened demand.
The company slashed its 2025 earnings guidance from $2.20 to $2.30 per share down to $0.40 to $0.50 per share. That represents more than an 80% reduction.
Securities Class Action Lawsuit Filed and Transferred to Minnesota District Court
A securities class action lawsuit was filed against Inspire Medical and certain executives. The complaint charges them with failing to disclose material information in violation of federal securities laws. The case was recently transferred from the United States District Court for the Southern District of New York to the District of Minnesota. The litigation remains ongoing.
KSF Investigation Focuses on Fiduciary Duty Breaches by Officers and Directors
KSF's investigation centers on whether Inspire's officers and directors breached fiduciary duties to shareholders. The firm is also examining potential violations of state or federal laws. The investigation seeks to determine if company leadership knowingly misrepresented the readiness of the Inspire V device for commercial launch.
Long-term shareholders may have legal recourse. The firm is gathering information from investors who held shares during the period when the company made statements about the device launch.
Medical Device Companies Face Heightened Scrutiny Over Product Launch Disclosures
The Inspire Medical situation highlights operational risks when medical device manufacturers launch new products. Training requirements for medical centers, software integration for claims processing, and inventory management all affect commercial success. Companies must accurately disclose these implementation challenges to investors.
Buyers and operators in the healthcare sector should note that device launches require coordination across multiple stakeholders. Incomplete training programs can delay adoption. Software systems must be ready for claims processing before widespread deployment.
Former Louisiana Attorney General Leads Boutique Securities Litigation Practice
Kahn Swick & Foti operates as a boutique securities litigation law firm with offices in New York, Delaware, California, Louisiana, and Chicago. The firm maintains a representative office in Luxembourg. KSF was ranked by SCAS among the top 10 firms nationally based on total settlement value in the past year.
The firm serves public and private institutional investors and retail investors seeking recoveries for investment losses from corporate fraud or malfeasance by publicly traded companies. Charles C. Foti, Jr., a managing partner, previously served as Attorney General of Louisiana.
Shareholders Can Contact KSF Without Obligation or Cost
Investors who hold information that could assist the investigation or long-term Inspire Medical shareholders may contact KSF without obligation or cost. The firm offers a toll-free number at 1-833-938-0905. Managing Partner Lewis Kahn can be reached directly by email. The firm has published additional case information on its website.
For more information about the ongoing investigation into Inspire Medical Systems, Inc., or to discuss legal rights as a shareholder, visit https://www.ksfcounsel.com/cases/nyse-insp/